Researchers close enough to developing vaccine against Leishmaniasis

(If you're not yet a fan, join us now by clicking the Like button)

A recent report talks about how researchers are trying to develop a vaccine which might be able to protect one from a lethal infectious parasite. In the name of Visceral leishmaniasis, the parasite killer is being treated harsh enough just after malaria.

It has been made clear by the team from The University of Western Australia that the parasite actually passes to organs such as liver, spleen and bone marrow, and there are potential chances of claiming one’s life if not being dealt at right time.

Backed by researchers from India, Brazil, UK, Australia and the USA, UWA Winthrop Professor Jenefer Blackwell, Head, Genetics and Health, Telethon Institute for Child Health Research, managed to track down main region of the major immune response locus, which is reported as the major histocompatibility complex (MHC), which is apparently treated as the key factor behind the disease.

“Earlier genetic studies of visceral leishmaniasis in inbred mice allowed us to clearly demonstrate the importance of the MHC in regulating this disease”, said the lead author in Nature Genetics.

If reports are to be believed, there are as many as 12 million people affected by the same, with as much as estimated 1.5 million new cases annually are reported especially in India, Bangladesh, Nepal, Sudan, South Sudan, Ethiopia and Brazil.

Researchers close enough to developing vaccine against Leishmaniasis


Comments are closed.